Laboratorios Farma | ROVI - 贸易债权人

金融业

EUR

EUR 799.88M

现金及等价物

EUR 46.11M

EUR 186.09M

EUR 509.33M

EUR 199.84M

EUR 129.3M

股息收益率

2.15

EUR 135.05M

EUR 34.94M

1.99K

EPS每股收益

EUR 1.96

股本和储备

EUR 539.39M

EUR 105.28M

债务利息支出

EUR 699K

EUR 139K

EUR 80.5M

EUR 3.13B

EUR 103.69M

EUR 313.62M

EUR 135.05M

普通股股本

EUR 51.82M

18.78

EUR 26.78M

EUR 448.66M

销售和管理费用

EUR 35.32M

EUR 327.67M

贸易债权人

EUR 107.59M

应收帐款人

EUR 143.38M

	贸易债权人	更改		日
Akebia Therapeutics	USD 9.42M		1.04M	2026-06
Alaunos Therapeutics	USD 400K		213K	2026-03
Almirall	EUR 235.53M		22.52M	2026-06
Avita Medical	AUD 8.96M		1.69M	2025-12
Dianthus Therapeutics	USD 6.39M		1.12M	2026-06
Ionis Pharmaceuticals	USD 47.7M		21.67M	2026-06
IQVIA Holdings	USD 3.61B		31M	2026-06
Laboratorios Farma	EUR 107.59M		341K	2023-12
Moderna	USD 167M		6M	2026-06
Organon & Co	USD 1.05B		68M	2026-06
Pharma Mar	EUR 38.93M		4.9M	2026-06
Revvity	USD 165.74M		3.94M	2026-06
Tectonic Therapeutic	USD 2.55M		1.46M	2026-03
Viatris	USD 1.24B		40.6M	2026-06
Xeris Pharmaceuticals	USD 9.34M		2.13M	2026-06